International outcomes in breast, cervical, and ovarian cancers highlight opportunities to improve health-care delivery for ...

One in five women with breast or cervical cancer in low- and middle-income countries (LMICs) are diagnosed at an early stage, ...

A growing number of people are getting genetic testing for breast cancer, which has become more comprehensive and ...

Some experts worry about the risk of overdiagnosis of benign conditions and the lack of research showing AI technology ...

Siemens Healthineers will leverage its regional network and healthcare technology expertise to support the adoption of Aiforia's pathology tools.

With a new type of analysis powered by artificial intelligence, doctors may be able to predict whether or not you’ll develop ...

Rates of one type of breast cancer — invasive lobular carcinoma — have been rising in the United States more than three times ...

The American Cancer Society estimates that in 2025, more than 315,000 women in the United States will be diagnosed with new ...

October marks Global Breast Cancer Awareness Month with several ASX companies working to advance early detection and ...

Her research forms part of a wider initiative to bridge traditional medicine and modern oncology, with the goal of one day ...

Gone are the days when breast cancer screening meant discomfort, radiation, and anxiety. This Breast Cancer Awareness Month, ...

Standard cancer screenings in the U.S. overlook nearly 70% of cancers and cancer subtypes. Multiple-cancer early detection (MCED) blood tests can help identify cancer biomarkers for multiple cancer ...